Accuracy and External Validation of mREMS in Road Traffic Injuries
Launched by AL-NAHRAIN UNIVERSITY · Dec 14, 2024
Trial Information
Current as of May 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Modified Rapid Emergency Medicine Score (mREMS) to see how well it can predict the outcomes for patients who have been injured in road traffic accidents. The researchers are particularly interested in understanding how accurate this scoring system is in a local hospital setting in Baghdad. By using mREMS, they hope to better assess patients' conditions when they arrive at the emergency department and to track their recovery, including whether they need surgery, how long they stay in the hospital, and their overall health outcomes.
To participate in this trial, patients must have been injured in a road traffic accident and come to the emergency department within four hours of their injury. They will need to give permission for their medical information to be used, or a family member can provide consent if they are unable to do so. Participants will have their health monitored throughout their hospital stay, and the study aims to gather important data to improve care for future patients with similar injuries. It's important to note that patients with other types of injuries, pregnant women, or those with serious pre-existing health conditions may not be eligible to join the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with road traffic injuries (RTIs) admitted to the emergency department.
- • Written informed consent provided by the patient or a legal representative (if the patient is unconscious or unable to provide consent).
- • Patients presenting to the emergency department within 4 hours of the injury.
- • Availability of complete physiological data for MREMS calculation.
- • Patients whose clinical outcomes (e.g., mortality, length of hospital stay, need for intensive care) are available for follow-up and analysis.
- Exclusion Criteria:
- • Patients with injuries not related to road traffic accidents (e.g., falls, burns, or violence-related injuries).
- • Pregnant women, due to the potential risk involved in the study and unique considerations in trauma care.
- • Patients with pre-existing severe chronic conditions (e.g., end-stage renal disease, terminal cancer) that could severely affect outcomes.
- • Patients who are unable or unwilling to provide informed consent.
- • Patients who were transferred from another hospital.
- • Incomplete or missing data for mREMS parameters.
- • Patients who leave against medical advice (LAMA) or are discharged before outcome data can be collected.
About Al Nahrain University
Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
Bashar A Abdulhassan, Assistant professor of surgery
Study Director
College Of Medicine - Nahrain University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported